Search Results 661-670 of 19237 for hemoglobin

1. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood in Patients With Relapsed and Resistant Ovarian Cancer - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL;; Platelet count ³30,000/mm3;; Total bilirubin ≤2.0 mg/dL unless patient has documented Gilbert's syndrome (Subjects with Gilbert's ...

2. Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III - Mayo Clinic

   Hemoglobin less than 12 mg/dL. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

3. A Study to Assess the Efficacy and Safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) - Mayo Clinic

   duration of the study and 30 days following the last dose of study drug. Exclusion Criteria: - Subject has severe anemia defined as hemoglobin <8.0 g/dL (<4.9 ...

4. Intracranial hematoma - Symptoms and causes - Mayo Clinic

   It's usually caused by a blood vessel that bursts in the brain. It also may be caused by a head injury due to a car accident or fall.

5. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Hemoglobin >=8.0 g/dL;; Platelets>= 50 X 10^9/L;; Total bilirubin <=1.5X Upper limit of normal (ULN). Isolated bilirubin >=1.5xULN is acceptable if bilirubin ...

6. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (9 g/dL is equivalent to 90 g/L and 5.59 mmol/L). Hepatic: Total bilirubin ≤ 1.5 x the institutional upper limit of normal (ULN). For ...

7. Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical - Mayo Clinic

   Preoperative hemoglobin <10g/dL; International Normalized Ratio>1.4; Abnormal Partial Thromboplastin Time; Preoperative platelet count of <150,000mm^3 ...

8. Ezetimibe (oral route) - Side effects & dosage - Mayo Clinic

   Description. Ezetimibe is used alone or combination with diet and other cholesterol-lowering medicines (eg, fenofibrate, statins) to treat high cholesterol ...

9. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers - Mayo Clinic

   Absolute neutrophil count (ANC) \< 1.5 x 109/L, hemoglobin \< 10 g/dL, or platelet count \< 100 x 109/L * QT interval corrected by Fridericia's formula ...

10. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

    Hemoglobin ≥ 10 g/dL; Creatinine ≤ 1.5 times the upper limit of normal with creatinine clearance ≥ 50 mL/min using the Modified Cockcroft-Gault method ...